AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACISTS TEST-AND-TREAT AUTHORITY ACT (Authorizes pharmacists to order, perform and interpret CLIA-waived tests authorized by statewide protocol and prescribe medications, and permits coverage by all health insurance carriers.)

H7921

2026 -- H 7921
========
LC005314
========

STATE OF RHODE ISLAND
IN GENERAL ASSEMBLY
JANUARY SESSION, A.D. 2026
____________
A N A C T
RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACISTS TEST-AND-TREAT
AUTHORITY ACT

Introduced By:
Representatives McGaw, Donovan, Tanzi, Boylan, Cruz, Furtado, Potter,
Giraldo, Kislak, and Cotter

Date Introduced:
February 27, 2026

Referred To:
House Health & Human Services
It is enacted by the General Assembly as follows:
1
SECTION 1. The general assembly hereby finds that:
2
(1) Timely access to testing and treatment for common, self-limiting, and communicable
3
conditions is essential to protecting public health.
4
(2) Licensed pharmacists are among the most accessible health care professionals and are
5
trained in medication therapy management, clinical assessment, and patient counseling.
6
(3) Expanding pharmacist authority to test for and treat certain conditions improves access
7
to care, reduces unnecessary emergency department and urgent care utilization, and supports health
8
system capacity.
9
(4) Pharmacist-provided test-and-treat services have been demonstrated to be safe,
10
effective, and acceptable to patients when conducted pursuant to evidence-based protocols.
11
SECTION 2. Title 5 of the General Laws entitled "BUSINESSES AND PROFESSIONS"
12
is hereby amended by adding thereto the following chapter:
13
CHAPTER 19.4
14
PHARMACISTS TEST-AND-TREAT AUTHORITY ACT
15

5-19.4-1. Short title.

16

This chapter shall be known and may be cited as the “Pharmacists Test-and-Treat Authority
17
Act”.
18

5-19.4-2. Purpose.

1

The purpose of this chapter is to authorize licensed pharmacists to independently test for
2
and initiate treatment of certain conditions.
3

5-19.4-3. Definitions.

4

As used in this chapter, the following terms shall have the following meanings:
5

(1) “Board” means the board of pharmacy established pursuant to §§ 5-19.1-3 through 5-
6
19.1-6.
7

(2) “CLIA-waived test” means a laboratory test categorized as waived under 42 CFR §
8
493.15
9

(3) “Department” means the department of health.
10

(4) “Pharmacist” means an individual licensed under chapter 19.1 of title 5 ("pharmacies").
11

(5) “Test-and-treat service” means the performance of a clinical assessment, the ordering
12
or administration of a clinical laboratory improvement amendments (CLIA)-waived test, the
13
interpretation of test results, and the initiation, modification, or discontinuation of drug therapy
14
pursuant to a statewide protocol.
15

5-19.4-4. Authority to provide test-and-treat services.

16

(a) Notwithstanding any provision of law to the contrary, a pharmacist may independently
17
provide test-and-treat services for conditions authorized by statewide protocol adopted by the board
18
pursuant to §§ 5-19.4-5 and 5-19.4-10.
19

(b) A pharmacist acting pursuant to this chapter may:
20

(1) Order, perform, and interpret CLIA-waived tests;
21

(2) Initiate, dispense, administer, or prescribe medications; and
22

(3) Provide patient counseling, education, and referral as clinically indicated.
23

(c) A pharmacist shall not provide test-and-treat services for any condition not expressly
24
authorized by statewide protocol.
25

5-19.4-5. Authorized conditions.

26

(a) The board, in consultation with the department, shall adopt statewide protocols
27
authorizing pharmacist test-and-treat services for conditions including, but not limited to:
28

(1) Influenza;
29

(2) COVID-19;
30

(3) Group A streptococcal pharyngitis;
31

(4) Post exposure prophylaxis (PEP) for sexually transmitted infections for which CLIA-
32
waived testing is available, unless testing is not readily available and delay in treatment may
33
increase risk of infection; and
34

(5) Any additional condition determined by the board to be appropriate based on safety,

LC005314 - Page 2 of 7
1
evidence, and public health needs.
2

(b) In adopting or amending protocols, the board shall consider:
3

(1) Evidence-based clinical guidelines;
4

(2) Diagnostic reliability of available tests;
5

(3) Medication safety and appropriateness; and
6

(4) Referral criteria and exclusion conditions.
7

5-19.4-6. Training and competency.

8

(a) Prior to providing test-and-treat services, a pharmacist shall complete education
9
requirements established by the board, which may include:
10

(1) Disease-specific education;
11

(2) Use and interpretation of CLIA-waived tests;
12

(3) Patient assessment and referral; and
13

(4) Documentation and reporting requirements.
14

(b) The board may require ongoing continuing education as a condition of continued
15
authority for a pharmacist to provide test-and-treat services pursuant to the provisions of this
16
chapter.
17

5-19.4-7. Documentation and communication.

18

(a) A pharmacist shall document each test-and-treat encounter in a patient record consistent
19
with board rules and regulations adopted pursuant to § 5-19.4-10.
20

(b) Upon patient consent, the pharmacist shall make reasonable efforts to notify the
21
patient’s primary care provider, if one exists, of the service provided within seven (7) business
22
days.
23

(c) Pharmacists shall comply with all applicable public health reporting requirements.
24

5-19.4-8. Liability and standard of care.

25

(a) A pharmacist providing services pursuant to the provisions of this chapter shall be held
26
to the standard of care applicable to pharmacists practicing within their scope of licensure.
27

(b) Nothing in this chapter shall be construed to create a higher standard of care or to
28
expand civil liability beyond existing law.
29

5-19.4-9. Reimbursement.

30

(a) Test-and-treat services provided pursuant to this chapter shall constitute covered health
31
care services for purposes of reimbursement under state-regulated health insurance plans and
32
Medicaid, subject to applicable billing requirements.
33

(b) The office of the health insurance commissioner and the executive office of health and
34
human services shall take actions necessary to implement this section.

LC005314 - Page 3 of 7
1

5-19.4-10. Rulemaking authority.

2

The board of pharmacy, in consultation with the department of health, shall promulgate
3
rules and regulations necessary to implement and enforce the provisions of this chapter. The rules
4
and regulations shall be promulgated no later than six (6) months after the effective date of this
5
chapter.
6

5-19.4-11. Severability.

7

If any provision of this chapter or its application is held invalid, the invalidity shall not
8
affect other provisions or applications of the chapter that can be given effect without the invalid
9
provision or application.
10
SECTION 3. Chapter 27-18 of the General Laws entitled "Accident and Sickness Insurance
11
Policies" is hereby amended by adding thereto the following section:
12

27-18-96. Coverage for pharmacists’ services.

13

(a) Every group health insurance contract, or every group hospital or medical expense
14
insurance policy, plan, or group policy delivered, issued for delivery, or renewed in this state, by
15
any health insurance carrier, on or after January 1, 2027, shall provide coverage for the services
16
within the lawful scope of practice of pharmacists as defined in § 5-19.1-2 if the plan would have
17
provided coverage if the service had been performed by a physician, advanced practice nurse, or
18
physician assistant. No nonprofit medical service corporation may require supervision, signature,
19
or referral by any other healthcare provider as a condition of reimbursement to a pharmacist;
20
provided that, no nonprofit medical service corporation may be required to pay for duplicative
21
services actually rendered by both a pharmacist and any other healthcare provider.
22

(b) The health plan shall include an adequate number of pharmacists in its network of
23
participating medical providers. The participation of pharmacies in the plan network’s drug benefit
24
does not satisfy the requirement that plans include pharmacists in their networks of participating
25
medical providers.
26

(c) The healthcare benefits outlined in this section shall apply only to services delivered
27
within the health insurer’s provider network; provided that, all health insurers shall be required to
28
provide coverage for those benefits mandated by this section outside of the health insurer’s provider
29
network where it can be established that the required services are not available from a provider in
30
the health insurer’s network.
31
SECTION 4. Chapter 27-19 of the General Laws entitled "Nonprofit Hospital Service
32
Corporations" is hereby amended by adding thereto the following section:
33

27-19-88. Coverage for pharmacists’ services.

34

(a) Every group health insurance contract, or every group hospital or medical expense

LC005314 - Page 4 of 7
1
insurance policy, plan, or group policy delivered, issued for delivery, or renewed in this state, by
2
any health insurance carrier, on or after January 1, 2027, shall provide coverage for the services
3
within the lawful scope of practice of pharmacists as defined in § 5-19.1-2 if the plan would have
4
provided coverage if the service had been performed by a physician, advanced practice nurse, or
5
physician assistant. No nonprofit medical service corporation may require supervision, signature,
6
or referral by any other healthcare provider as a condition of reimbursement to a pharmacist;
7
provided that, no nonprofit medical service corporation may be required to pay for duplicative
8
services actually rendered by both a pharmacist and any other healthcare provider.
9

(b) The health plan shall include an adequate number of pharmacists in its network of
10
participating medical providers. The participation of pharmacies in the plan network’s drug benefit
11
does not satisfy the requirement that plans include pharmacists in their networks of participating
12
medical providers.
13

(c) The healthcare benefits outlined in this section shall apply only to services delivered
14
within the health insurer’s provider network; provided that, all health insurers shall be required to
15
provide coverage for those benefits mandated by this section outside of the health insurer’s provider
16
network where it can be established that the required services are not available from a provider in
17
the health insurer’s network.
18
SECTION 5. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service
19
Corporations" is hereby amended by adding thereto the following section:
20

27-20-84. Coverage for pharmacists’ services.

21

(a) Every group health insurance contract, or every group hospital or medical expense
22
insurance policy, plan, or group policy delivered, issued for delivery, or renewed in this state, by
23
any health insurance carrier, on or after January 1, 2027, shall provide coverage for the services
24
within the lawful scope of practice of pharmacists as defined in § 5-19.1-2 if the plan would have
25
provided coverage if the service had been performed by a physician, advanced practice nurse, or
26
physician assistant. No nonprofit medical service corporation may require supervision, signature,
27
or referral by any other healthcare provider as a condition of reimbursement to a pharmacist;
28
provided that, no nonprofit medical service corporation may be required to pay for duplicative
29
services actually rendered by both a pharmacist and any other healthcare provider.
30

(b) The health plan shall include an adequate number of pharmacists in its network of
31
participating medical providers. The participation of pharmacies in the plan network’s drug benefit
32
does not satisfy the requirement that plans include pharmacists in their networks of participating
33
medical providers.
34

(c) The healthcare benefits outlined in this section shall apply only to services delivered

LC005314 - Page 5 of 7
1
within the health insurer’s provider network; provided that, all health insurers shall be required to
2
provide coverage for those benefits mandated by this section outside of the health insurer’s provider
3
network where it can be established that the required services are not available from a provider in
4
the health insurer’s network.
5
SECTION 6. Chapter 27-41 of the General Laws entitled "Health Maintenance
6
Organizations" is hereby amended by adding thereto the following section:
7

27-41-101. Coverage for pharmacists’ services.

8

(a) Every group health insurance contract, or every group hospital or medical expense
9
insurance policy, plan, or group policy delivered, issued for delivery, or renewed in this state, by
10
any health insurance carrier, on or after January 1, 2027, shall provide coverage for the services
11
within the lawful scope of practice of pharmacists as defined in § 5-19.1-2 if the plan would have
12
provided coverage if the service had been performed by a physician, advanced practice nurse, or
13
physician assistant. No nonprofit medical service corporation may require supervision, signature,
14
or referral by any other healthcare provider as a condition of reimbursement to a pharmacist;
15
provided that, no nonprofit medical service corporation may be required to pay for duplicative
16
services actually rendered by both a pharmacist and any other healthcare provider.
17

(b) The health plan shall include an adequate number of pharmacists in its network of
18
participating medical providers. The participation of pharmacies in the plan network’s drug benefit
19
does not satisfy the requirement that plans include pharmacists in their networks of participating
20
medical providers.
21

(c) The healthcare benefits outlined in this section shall apply only to services delivered
22
within the health insurer’s provider network; provided that, all health insurers shall be required to
23
provide coverage for those benefits mandated by this section outside of the health insurer’s provider
24
network where it can be established that the required services are not available from a provider in
25
the health insurer’s network.
26
SECTION 7. This act shall take effect on January 1, 2027.
========
LC005314
========

LC005314 - Page 6 of 7
EXPLANATION
BY THE LEGISLATIVE COUNCIL
OF
A N A C T
RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACISTS TEST-AND-TREAT
AUTHORITY ACT
***
1
This act would authorize pharmacists to order, perform and interpret CLIA-waived tests
2
authorized by statewide protocol and prescribe medications. This act would further permit for such
3
test-and-treat authority to be covered by all health insurance carriers.
4
This act would take effect on January 1, 2027.
========
LC005314
========

LC005314 - Page 7 of 7